| abstract |
The present invention relates to a novel selective androgen receptor agonist, a process for its preparation, and a pharmaceutical composition containing the pharmacologically effective amount thereof. The selective androgen receptor agonists according to the present invention act on the androgen receptors to increase the activity of the androgen receptors, thereby improving the symptoms and the diseases or conditions which can respond to the treatment due to the increase of the androgen receptor activity, Hormone related diseases, muscular exhaustion disorders, osteoporosis, and the like. |